New Trials Offer Hope for Type 1 Diabetic Kidney Disease Ramiro Navarro logo Medscape Europe May 07, 2026

https://www.medscape.com/viewarticle/new-trials-offer-hope-type-1-diabetic-kidney-disease-2026a1000eqz Three therapeutic lines in development — SGLT2 inhibitors, finerenone, and GLP-1 receptor agonists — highlighted at the 37th National Congress of the Spanish Diabetes Society Foundation (FSED), held on April 15-17 in Seville, Spain.